{
    "paper_id": "2ca80c0de68d8e14e0cd2263dc80783707feaa42",
    "metadata": {
        "title": "Liver injury in remdesivir-treated COVID-19 patients",
        "authors": [
            {
                "first": "Rosa",
                "middle": [],
                "last": "Zampino",
                "suffix": "",
                "affiliation": {
                    "laboratory": "",
                    "institution": "University of Campania 'L. Vanvitelli' and Units",
                    "location": {
                        "settlement": "Napoli",
                        "country": "Italy"
                    }
                },
                "email": ""
            },
            {
                "first": "Ferruccio",
                "middle": [],
                "last": "Mele",
                "suffix": "",
                "affiliation": {
                    "laboratory": "",
                    "institution": "University of Campania 'L. Vanvitelli' and Units",
                    "location": {
                        "settlement": "Napoli",
                        "country": "Italy"
                    }
                },
                "email": ""
            },
            {
                "first": "\u00b7",
                "middle": [],
                "last": "Letizia",
                "suffix": "",
                "affiliation": {},
                "email": ""
            },
            {
                "first": "Lucia",
                "middle": [],
                "last": "Florio",
                "suffix": "",
                "affiliation": {
                    "laboratory": "",
                    "institution": "University of Campania 'L. Vanvitelli' and Units",
                    "location": {
                        "settlement": "Napoli",
                        "country": "Italy"
                    }
                },
                "email": ""
            },
            {
                "first": "\u00b7",
                "middle": [
                    "Lorenzo"
                ],
                "last": "Bertolino",
                "suffix": "",
                "affiliation": {
                    "laboratory": "",
                    "institution": "University of Campania 'L. Vanvitelli' and Units",
                    "location": {
                        "settlement": "Napoli",
                        "country": "Italy"
                    }
                },
                "email": ""
            },
            {
                "first": "Roberto",
                "middle": [],
                "last": "Andini",
                "suffix": "",
                "affiliation": {
                    "laboratory": "",
                    "institution": "AORN Ospedali dei Colli-Monaldi Hospital",
                    "location": {
                        "settlement": "Napoli",
                        "country": "Italy"
                    }
                },
                "email": ""
            },
            {
                "first": "Maria",
                "middle": [],
                "last": "Galdo",
                "suffix": "",
                "affiliation": {
                    "laboratory": "",
                    "institution": "AORN Ospedali dei Colli-Monaldi Hospital",
                    "location": {
                        "settlement": "Naples",
                        "country": "Italy"
                    }
                },
                "email": ""
            },
            {
                "first": "Rosanna",
                "middle": [],
                "last": "De Rosa",
                "suffix": "",
                "affiliation": {
                    "laboratory": "",
                    "institution": "AORN Ospedali dei Colli-Monaldi Hospital",
                    "location": {
                        "settlement": "Naples",
                        "country": "Italy Hepatology International"
                    }
                },
                "email": ""
            },
            {
                "first": "Antonio",
                "middle": [],
                "last": "Corcione",
                "suffix": "",
                "affiliation": {
                    "laboratory": "",
                    "institution": "AORN Ospedali dei Colli-Monaldi Hospital",
                    "location": {
                        "settlement": "Naples",
                        "country": "Italy Hepatology International"
                    }
                },
                "email": ""
            },
            {
                "first": "Emanuele",
                "middle": [],
                "last": "Durante-Mangoni",
                "suffix": "",
                "affiliation": {
                    "laboratory": "",
                    "institution": "University of Campania 'L. Vanvitelli' and Units",
                    "location": {
                        "settlement": "Napoli",
                        "country": "Italy"
                    }
                },
                "email": ""
            }
        ]
    },
    "abstract": [],
    "body_text": [
        {
            "text": "with lopinavir/ritonavir (LPV/r, 400/100 mg twice daily po). Before and during RDV treatment, 4 of 5 patients also received hydroxychloroquine (HCQ, 200 mg twice daily po). While on RDV, no patient received acetaminophen, patient 2 and 4 received ceftazidime-avibactam plus daptomycin and patient 3 meropenem and linezolid. None of the 5 treated patients had a previous history of liver disease, visceral obesity, viral hepatitis, or prior hepatotoxic medication or alcohol intake. Liver ultrasound did not show signs of advanced liver disease. Patient 1 and 2 had a history of hypertension and asthma, respectively, but were not receiving any relevant therapy in the ICU. Figure 1 describes the dynamics of AST/ALT and bilirubin throughout the hospital stay, for each patient (Panels 1-5). In Panel 6, we report a comparison of median ALT and AST levels between RDV-treated patients and 5 COVID-19 patients who were treated in our Hospital ICU with the same schedule of LPV/r and HCQ, but without RDV. As shown in Panels 1-5, bilirubin increase occurred in 4 of 5 index patients on LPV/r. In contrast, the switch to RDV translated into a fast reduction of bilirubin and a significant increase in AST/ALT by day 3 of therapy in 4 of 5 patients. The single patient who did not receive HCQ with RDV (patient 4) did not show increase of ALT/AST levels. In no cases, RDV was discontinued because of liver injury. In patient 1, RDV was withdrawn at day 5 for a torsade de pointes requiring cardiac resuscitation, whereas patient 3 died on day 5 of RDV therapy. Final outcome was positive in 4/5 patients.",
            "cite_spans": [],
            "ref_spans": [
                {
                    "start": 673,
                    "end": 681,
                    "text": "Figure 1",
                    "ref_id": "FIGREF0"
                }
            ],
            "section": ""
        },
        {
            "text": "Our observation supports previous findings obtained in healthy volunteers (Gilead Sciences, data on file) and COVID-19 patients treated with RDV [4, 5] , suggesting this antiviral may cause hepatocellular injury. In our patients, this adverse effect neither progressed to severe liver damage nor induced liver failure, although none had a prior chronic liver disease. Although SARS-CoV-2 infection can cause aminotransferase elevation per se, 4 of our 5 patients had normal or slightly elevated AST/ALT levels at RDV treatment start, suggesting a direct role of RDV in hepatocellular toxicity. Despite the overall low number of patients ",
            "cite_spans": [
                {
                    "start": 145,
                    "end": 148,
                    "text": "[4,",
                    "ref_id": "BIBREF3"
                },
                {
                    "start": 149,
                    "end": 151,
                    "text": "5]",
                    "ref_id": "BIBREF4"
                }
            ],
            "ref_spans": [],
            "section": ""
        }
    ],
    "bib_entries": {
        "BIBREF0": {
            "ref_id": "b0",
            "title": "A comparative study on the clinical features of COVID-19 pneumonia to other pneumonias",
            "authors": [
                {
                    "first": "D",
                    "middle": [],
                    "last": "Zhao",
                    "suffix": ""
                },
                {
                    "first": "F",
                    "middle": [],
                    "last": "Yao",
                    "suffix": ""
                },
                {
                    "first": "L",
                    "middle": [],
                    "last": "Wang",
                    "suffix": ""
                },
                {
                    "first": "L",
                    "middle": [],
                    "last": "Zheng",
                    "suffix": ""
                },
                {
                    "first": "Y",
                    "middle": [],
                    "last": "Gao",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Ye",
                    "suffix": ""
                }
            ],
            "year": 2020,
            "venue": "Clin Infect Dis",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {
                "DOI": [
                    "10.1093/cid/ciaa247"
                ]
            }
        },
        "BIBREF1": {
            "ref_id": "b1",
            "title": "Liver injury during highly pathogenic human coronavirus infections",
            "authors": [
                {
                    "first": "L",
                    "middle": [],
                    "last": "Xu",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Liu",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Lu",
                    "suffix": ""
                },
                {
                    "first": "D",
                    "middle": [],
                    "last": "Yang",
                    "suffix": ""
                },
                {
                    "first": "X",
                    "middle": [],
                    "last": "Zheng",
                    "suffix": ""
                }
            ],
            "year": 2020,
            "venue": "Liver Int",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {
                "DOI": [
                    "10.1111/liv.14435"
                ]
            }
        },
        "BIBREF2": {
            "ref_id": "b2",
            "title": "COVID-19: an update on the epidemiological, clinical, preventive and therapeutic evidence and guidelines of integrative Chinese-western medicine for the management of 2019 novel coronavirus disease",
            "authors": [
                {
                    "first": "K",
                    "middle": [
                        "W"
                    ],
                    "last": "Chan",
                    "suffix": ""
                },
                {
                    "first": "V",
                    "middle": [
                        "T"
                    ],
                    "last": "Wong",
                    "suffix": ""
                },
                {
                    "first": "Scw",
                    "middle": [],
                    "last": "Tang",
                    "suffix": ""
                }
            ],
            "year": 2020,
            "venue": "Am J Chin Med",
            "volume": "13",
            "issn": "",
            "pages": "1--26",
            "other_ids": {
                "DOI": [
                    "10.1142/S0192415X20500378"
                ]
            }
        },
        "BIBREF3": {
            "ref_id": "b3",
            "title": "Compassionate use of remdesivir for patients with severe covid-19",
            "authors": [
                {
                    "first": "J",
                    "middle": [],
                    "last": "Grein",
                    "suffix": ""
                },
                {
                    "first": "N",
                    "middle": [],
                    "last": "Ohmagari",
                    "suffix": ""
                },
                {
                    "first": "D",
                    "middle": [],
                    "last": "Shin",
                    "suffix": ""
                },
                {
                    "first": "G",
                    "middle": [],
                    "last": "Diaz",
                    "suffix": ""
                },
                {
                    "first": "E",
                    "middle": [],
                    "last": "Asperges",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "Castagna",
                    "suffix": ""
                }
            ],
            "year": 2020,
            "venue": "N Engl J Med",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {
                "DOI": [
                    "10.1056/NEJMoa2007016"
                ]
            }
        },
        "BIBREF4": {
            "ref_id": "b4",
            "title": "Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial",
            "authors": [
                {
                    "first": "Y",
                    "middle": [],
                    "last": "Wang",
                    "suffix": ""
                },
                {
                    "first": "D",
                    "middle": [],
                    "last": "Zhang",
                    "suffix": ""
                },
                {
                    "first": "G",
                    "middle": [],
                    "last": "Du",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [],
                    "last": "Du",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Zhao",
                    "suffix": ""
                },
                {
                    "first": "Y",
                    "middle": [],
                    "last": "Jin",
                    "suffix": ""
                }
            ],
            "year": 2020,
            "venue": "Lancet",
            "volume": "",
            "issn": "20",
            "pages": "31022--31031",
            "other_ids": {
                "DOI": [
                    "10.1016/S0140-6736(20)31022-9"
                ]
            }
        }
    },
    "ref_entries": {
        "FIGREF0": {
            "text": "Dynamics of ALT, AST and bilirubin in the 5 patients treated with Remdesivir (Panels[1][2][3][4][5]. Aminotransferase values are shown as times the upper normal limit. Antivirals given are shown on top of each graph. Panel 6 shows a comparison of median ALT and AST levels between the 5 RDV-treated patients and 5 additional COVID-19 patients who were treated in our Hospital ICU with the same schedule of LPV/r and HCQ but without RDV. LPV/r lopinavir/ritonavir, DRV/c darunavir/cobicistat, HCQ hydroxychloroquine, RDV remdesivir, UNL upper normal limit",
            "latex": null,
            "type": "figure"
        }
    },
    "back_matter": []
}